Peripheral CD4+ T cells correlate with response and survival in patients with advanced non-small cell lung cancer receiving chemo-immunotherapy

Peripheral CD4+ T cells correlate with response and survival in patients with advanced non-small cell lung cancer receiving chemo-immunotherapy

BackgroundThe aim of the present study was to explore the potential of peripheral immune cells in predicting the response and prognosis of patients with advanced non-small cell lung cancer (NSCLC) receiving anti-PD-1 immunotherapy and platinum-based chemotherapy.Participants and MethodsWe utilized f...

Full description

Bibliographic Details
Main Authors:	Xin Yang, Qiao Li, Tianyang Zeng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Immunology
Subjects:	chemoimmunotherapy lymphocyte subsets biomarker prognosis non-small cell lung cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1364507/full

Similar Items

A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first‐line therapy administration in patients with chronic lymphocytic leukemia
by: Pavel Vodárek, et al.
Published: (2023-03-01)

Peripheral blood T-lymphocyte subsets are potential biomarkers of disease severity and clinical outcomes in patients with ulcerative colitis: a retrospective study
by: Bailu Geng, et al.
Published: (2023-04-01)

Research progress of extracellular vesicles as biomarkers in immunotherapy for non-small cell lung cancer
by: Yang Ge, et al.
Published: (2023-04-01)

Prognostic significance of baseline peripheral blood lymphocyte subsets on second-line immunotherapy in advanced esophageal squamous cell carcinoma
by: Qike Wang, et al.
Published: (2023-08-01)

A combination of the percentages of IFN-γ+CD4+T cells and granzyme B+CD19+B cells is associated with acute hepatic rejection: a case control study
by: Ji-Qiao Zhu, et al.
Published: (2021-05-01)

A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma
by: Oladapo Yeku, et al.
Published: (2020-09-01)

CD8+ T Lymphocyte Infiltration: A Favourable Prognostic Indicator in Indian Patients with Breast Carcinoma
by: Deep Kumar Raman, et al.
Published: (2019-01-01)

Peripheral Blood CD8+ T-Lymphocyte Subsets Are Associated with Prognosis in Prostate Cancer Patients
by: Constantin N. Baxevanis, et al.
Published: (2023-07-01)

Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-CD20 monoclonal antibody: a systematic review and meta-analysis of prognostic factors
by: Zekhethelo A. Mkhwanazi, et al.
Published: (2022-11-01)

Dynamic changes of peripheral blood lymphocyte subsets in acute ischemic stroke and prognostic value
by: Jun Xiao, et al.
Published: (2021-01-01)

Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID-19
by: Zhifeng Deng, et al.
Published: (2020-09-01)

Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
by: Jin Kang, et al.
Published: (2021-04-01)

Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers
by: Nawar Maher, et al.
Published: (2023-06-01)

CD4+, CD8+ and CD4+CD25+ T lymphocytes in peripheral blood and peritoneal fluid of women with endometriosis - preliminary report
by: Jarosław Górski, et al.
Published: (2007-03-01)

Clinical Importance of Immunophenotyping of Peripheral Blood Lymphocyte Subsets in Adult COVID-19 Patients: A Cross-Sectional Study
by: Tuba KURUOĞLU, et al.
Published: (2023-09-01)

Effective Treatment of Patients Experiencing Primary, Acute HIV Infection Decreases Exhausted/Activated CD4+ T Cells and CD8+ T Memory Stem Cells
by: Domenico Lo Tartaro, et al.
Published: (2022-07-01)

Impact of the pretreatment prognostic nutritional index on the survival after first‐line immunotherapy in non‐small‐cell lung cancer patients
by: Yuka Oku, et al.
Published: (2023-07-01)

Cluster analysis of lymphocyte subset from peripheral blood in newly diagnosed idiopathic aplastic anaemia patients
by: Wei Yu, et al.
Published: (2022-12-01)

Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients
by: Yutuan Wu, et al.
Published: (2020-03-01)

Development and Validation of an Age-Related Gastric Cancer-Specific Immune Index
by: Wang H, et al.
Published: (2022-11-01)

Investigation of Lymphocyte Subsets in Peripheral Blood of Patients with Dyslipidemia
by: Xu DM, et al.
Published: (2021-09-01)

CD38 Multi-Functionality in Oral Squamous Cell Carcinoma: Prognostic Implications, Immune Balance, and Immune Checkpoint
by: Zhuang Ding, et al.
Published: (2021-06-01)

CD19+ B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity
by: J. Lu, et al.
Published: (2016-01-01)

CD19+ B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity
by: J. Lu, et al.
Published: (2016-08-01)

Dynamic surveillance of lymphocyte subsets in patients with non-small cell lung cancer during chemotherapy or combination immunotherapy for early prediction of efficacy
by: Shanshan Zhen, et al.
Published: (2024-02-01)

Impact of Perioperative Multiple Doses of Glucocorticoids on Peripheral Blood Lymphocyte Subsets and Inflammatory Cytokines in Patients With Non-small Cell Lung Cancer
by: Liuquan Yang, et al.
Published: (2022-03-01)

Entrance to the multifaceted world of CD4+ T cell subsets
by: Murilo Porfírio de Aguiar, et al.
Published: (2024-03-01)

Activated CD4 + T lymphocyte is a potential biomarker for acute graft-vs.-host disease after hematopoietic stem cell transplantation in children with transfusion-dependent β-thalassemia
by: Ken Huang, et al.
Published: (2022-09-01)

Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region
by: Francesco Autore, et al.
Published: (2020-06-01)

Clinical Significance of T Lymphocyte Subset Changes After First Line Chemotherapy in Peripheral Blood from Patients with Advanced Stage Adenocarcinoma Cell Lung Cancer
by: Xiang YAN, et al.
Published: (2012-03-01)

Exploring Perturbations in Peripheral B Cell Memory Subpopulations Early after Kidney Transplantation Using Unsupervised Machine Learning
by: Ariadni Fouza, et al.
Published: (2023-10-01)

Changes in circulating lymphocyte subpopulations in pigs receiving therapeutic doses of ceftiofur and tulathromycin
by: Czyżewska-Dors Ewelina, et al.
Published: (2016-12-01)

Prognostic Value of Tumor-Infiltrating Lymphocytes Differs Depending on Lymphocyte Subsets in Esophageal Squamous Cell Carcinoma: An Updated Meta-Analysis
by: Jiatao Hao, et al.
Published: (2020-04-01)

Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy
by: Yang Wang, M.B.B.S., et al.
Published: (2023-08-01)

IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB
by: M. N Khorobrykh, et al.
Published: (2014-07-01)

Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
by: Yulong Chen, et al.
Published: (2023-09-01)

Peripheral blood CD4+ T cell populations by CD25 and Foxp3 expression as a potential biomarker: reflecting inflammatory activity in chronic obstructive pulmonary disease
by: Meng ZJ, et al.
Published: (2019-07-01)

Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial
by: Raquel Laza‐Briviesca, et al.
Published: (2021-07-01)

Circulating cytokines associated with clinical outcomes in advanced non‐small cell lung cancer patients who received chemoimmunotherapy
by: Yuequan Shi, et al.
Published: (2022-01-01)

Intratumoral CD103+CD8+ T cells predict response to neoadjuvant chemoimmunotherapy in advanced head and neck squamous cell carcinoma
by: Siqi Ren, et al.
Published: (2023-10-01)